Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment - Takeaways - MDSpire

Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment

  • By

  • Jiayan Xu

  • Fei Qu

  • Xiaoyu Wang

  • Shuang Liang

  • Dongying Jiang

  • Zhenghua Wang

  • April 29, 2026

  • 0 min

Share

  • 1

    Preoperative HALP and LMR are independent predictors of disease-free survival in stage III colon cancer patients.

  • 2

    The study included 210 patients with stage III colon cancer and 220 patients with benign colonic lesions for comparison.

  • 3

    Multivariable analysis identified HALP, LMR, tumor stage, and chemotherapy cycles as significant predictors of disease-free survival.

  • 4

    A nomogram integrating inflammatory biomarkers and clinicopathological variables demonstrated good discrimination and calibration.

  • 5

    This research highlights the potential of inflammatory indices for individualized recurrence risk estimation in stage III colon cancer.

Original Source(s)

Preoperative HALP and LMR as Predictors of Disease-Free Survival in Stage III Colon Cancer: Implications for Nomogram-Based Risk Assessment

  • by Jiayan Xu, Fei Qu, Xiaoyu Wang, Shuang Liang, Dongying Jiang, Zhenghua Wang

  • April 29, 2026

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant